RedHill Biopharma’s Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant

Opaganib demonstrated strong inhibition of COVID-19 Delta variant in a human bronchial epithelial cells model, adding to prior data demonstrating potent inhibition of all COVID-19 variants tested to date    Opaganib’s unique, host-targeted, dual antiviral and anti-inflammatory approach to combatting COVID-19 is expected to maintain effect against other emerging variants The global 475-patient Phase 2/3 […]

thaipr.net

30 ส.ค. 64
1 2,835 2,836 2,837 2,838 2,839 3,345